MedTrace Logo

Home-based Self-sampling for Cervical Cancer Prevention Education Intervention in Ghana

NCT06800664 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1500

Last updated 2025-01-31

No results posted yet for this study

Summary

The investigators propose to develop and/or adapt implementation strategies and a structured implementation plan to translate the HOPE intervention into existing healthcare practice in Ghana.

These "implementation support strategies (ISS)" are implementation strategies relevant to implementation support, which is concerned with moving (implementation) research into (implementation) practice.

The ultimate goal is to facilitate health system adoption and sustainment.

Conditions

  • Cervical Cancer Screening
  • HIV
  • Self-sampling
  • Implementation Science
  • Intervention (Training) Condition
  • Implementation Strategies

Interventions

BEHAVIORAL

Health providers and management at IG sites will receive ISS (i.e., management support, capacity-building, and social network support) and training on the HOPE implementation plan

Health providers and management at IG sites will receive ISS (i.e., management support, capacity-building, and social network support) and training on the HOPE implementation plan

BEHAVIORAL

Control Group

Providers in the control group will not receive ISS support

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Baylor University

    lead OTHER

Principal Investigators

  • Matthew Asare, PhD · Baylor University

  • Dorcas Obiri-Yeboah, PhD · University of Cape Coast

  • Nadia Sam-Agudu, MD · University of Minnesota

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
25 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-30
Primary Completion
2028-11-30
Completion
2029-05-31

Countries

  • Ghana

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06800664 on ClinicalTrials.gov